{
  "company": {
    "name": "Aspect Biosystems",
    "website": "https://aspectbiosystems.com/",
    "record": "https://startuphistory.org/c/aspectbiosystems.com"
  },
  "status": null,
  "history_since": "2015-01-09T21:45:08.000Z",
  "baseline": {
    "snapshot_id": "273fcc4e9979996b8fe56b8854e918edbf8ded25ee4549224f0f6ffc47f8ecbd",
    "observed_at": "2015-01-09T21:45:08.000Z",
    "headline": "Aspect Biosystems | Human Tissues on Demand",
    "description": "Human Tissues on Demand",
    "evidence": "https://web.archive.org/web/20150109214508/http://aspectbiosystems.com:80/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [],
          "funding": [
            "The Aspect team is thrilled to announce that Aspect Biosystems was awarded second place and a $55,000 prize package at the prestigious BCIC New Ventures Competition!",
            "Aspect Biosystems is excited to announce an investment in the company from the e@UBC Seed Fund."
          ]
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T11:31:16.868Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2016-07-16T15:52:51.000Z",
      "variants": [
        {
          "headline": "Aspect Biosystems | Human Tissues on Demand",
          "subhead": "Human Tissues on Demand",
          "observed_at": "2015-01-09T21:45:08.000Z",
          "evidence": "https://web.archive.org/web/20150109214508/http://aspectbiosystems.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Aspect Biosystems | Human Tissues on Demand",
          "subhead": "Human Tissues on Demand",
          "observed_at": "2016-07-16T15:52:51.000Z",
          "evidence": "https://web.archive.org/web/20160716155251/http://aspectbiosystems.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Aspect Biosystems | Human Tissues on Demand",
      "subhead": "Human Tissues on Demand",
      "from": "2015-01-09T21:45:08.000Z",
      "to": "2016-07-16T15:52:51.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20160716155251/http://aspectbiosystems.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2015-01-09T21:45:08.000Z",
          "to": "2016-07-16T15:52:51.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2022-01-22T04:14:18.000Z",
      "variants": [
        {
          "headline": "3D BIOPRINTING AND TISSUE ENGINEERING",
          "subhead": "Aspect Biosystems is an award-winning biotechnology company specializing in 3D bioprinting and tissue engineering.",
          "observed_at": "2018-03-07T04:46:44.000Z",
          "evidence": "https://web.archive.org/web/20180307044644/https://www.aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "3D BIOPRINTING AND TISSUE ENGINEERING",
          "subhead": "Aspect Biosystems is an award-winning biotechnology company specializing in 3D bioprinting and tissue engineering.",
          "observed_at": "2019-07-11T23:06:27.000Z",
          "evidence": "https://web.archive.org/web/20190711230627/https://www.aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Microfluidic 3D Bioprinting",
          "subhead": "We combine the power of microfluidics and 3D bioprinting to create living, human tissues that will save lives and make people healthier.",
          "observed_at": "2020-09-04T17:50:28.000Z",
          "evidence": "https://web.archive.org/web/20200904175028/https://aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Microfluidic 3D Bioprinting",
          "subhead": "We combine the power of microfluidics and 3D bioprinting to create living, human tissues that will save lives and make people healthier.",
          "observed_at": "2022-01-22T04:14:18.000Z",
          "evidence": "https://web.archive.org/web/20220122041418/https://www.aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Microfluidic 3D Bioprinting",
      "subhead": "We combine the power of microfluidics and 3D bioprinting to create living, human tissues that will save lives and make people healthier.",
      "from": "2018-03-07T04:46:44.000Z",
      "to": "2022-01-22T04:14:18.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20220122041418/https://www.aspectbiosystems.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2018-03-07T04:46:44.000Z",
          "to": "2022-01-22T04:14:18.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T11:31:16.868Z",
      "variants": [
        {
          "headline": "transform how we treat disease",
          "subhead": "Developing bioprinted tissue therapeutics to transform how we treat disease.",
          "observed_at": "2023-09-26T03:20:40.000Z",
          "evidence": "https://web.archive.org/web/20230926032040/https://aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "transform how we treat disease",
          "subhead": "Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.",
          "observed_at": "2025-01-08T23:36:28.000Z",
          "evidence": "https://web.archive.org/web/20250108233628/https://www.aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "transform how we treat disease",
          "subhead": "Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.",
          "observed_at": "2026-07-14T03:49:53.000Z",
          "evidence": "https://web.archive.org/web/20260714034953/https://www.aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "transform how we treat disease",
          "subhead": "Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.",
          "observed_at": "2026-10-18T02:26:22.000Z",
          "evidence": "https://web.archive.org/web/20261018022622/https://www.aspectbiosystems.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "transform how we treat disease",
          "subhead": "Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.",
          "observed_at": "2026-11-05T11:31:16.868Z",
          "evidence": "https://aspectbiosystems.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "transform how we treat disease",
      "subhead": "Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.",
      "from": "2023-09-26T03:20:40.000Z",
      "to": "2026-11-05T11:31:16.868Z",
      "captures": 5,
      "evidence": "https://aspectbiosystems.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2023-09-26T03:20:40.000Z",
          "to": "2026-11-05T11:31:16.868Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-860b61f385c97dad6cb1a78dbde8c045fac2c62ae8a0baa11e039f423c008722:a9ea18818fe44a3bd2f7a60ff2217096885a3b306de7ed7e3b6e0d6d516b8fc6:funding:0bd06cc1f31d84a1",
      "before_evidence": "https://web.archive.org/web/20160716155251/http://aspectbiosystems.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “Aspect Biosystems Closes First Institutionally Led Round of Financing September 18, 2017 Aspect has announced the completion of its first…”.",
      "between": {
        "from": "2016-07-16T15:52:51.000Z",
        "to": "2018-03-07T04:46:44.000Z"
      },
      "evidence": "https://web.archive.org/web/20180307044644/https://www.aspectbiosystems.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-89b7f25e9ba0a5183a147a79b7e0901de83501e90c35f04a31141112c2474627:a1d4ec92be9789bd855b13043d1c6438a803685af39168b0f8ad01a73d70bb9e:headline:c010289266fffa7c",
      "before_evidence": "https://web.archive.org/web/20190711230627/https://www.aspectbiosystems.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “3D BIOPRINTING AND TISSUE ENGINEERING” to “Microfluidic 3D Bioprinting”.",
      "between": {
        "from": "2019-07-11T23:06:27.000Z",
        "to": "2020-09-04T17:50:28.000Z"
      },
      "evidence": "https://web.archive.org/web/20200904175028/https://aspectbiosystems.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "classifier-967ea3ed1a19c82a26932c65931782cb587665fc056e8112c150151b58b48daa:9a2ceae57ec5b4566b70e03841d3f4dc1b34e814f3b98ed99c46f1e11365ec6e:repositioning",
      "before_evidence": "https://web.archive.org/web/20220122041418/https://www.aspectbiosystems.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "repositioning",
      "label": "Messaging",
      "summary": "Changed its homepage headline from “Microfluidic 3D Bioprinting” to “transform how we treat disease”.",
      "between": {
        "from": "2022-01-22T04:14:18.000Z",
        "to": "2023-09-26T03:20:40.000Z"
      },
      "evidence": "https://web.archive.org/web/20230926032040/https://aspectbiosystems.com/",
      "evidence_kind": "internet_archive",
      "basis": "classifier",
      "topic": "https://startuphistory.org/t/repositioned"
    }
  ],
  "update": {
    "headline": "Aspect Biosystems funding and homepage messaging updates",
    "summary": "Aspect Biosystems disclosed an institutionally led funding round and has updated its homepage headlines, indicating shifts in how it frames its work and technology.",
    "points": [
      {
        "text": "Between July 2016 and March 2018, Aspect Biosystems announced on its homepage that it closed its first institutionally led round of financing, described as its first completed round.",
        "kind": "fact",
        "changes": [
          1
        ]
      },
      {
        "text": "Between July 2019 and September 2020, Aspect Biosystems changed its homepage headline from “3D BIOPRINTING AND TISSUE ENGINEERING” to “Microfluidic 3D Bioprinting”.",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "Between January 2022 and September 2023, a classifier read a homepage headline change from “Microfluidic 3D Bioprinting” to “transform how we treat disease” as a repositioning.",
        "kind": "fact",
        "changes": [
          3
        ]
      },
      {
        "text": "The shifts in homepage language in the periods July 2019–September 2020 and January 2022–September 2023 may suggest a move from emphasizing specific 3D bioprinting technology toward a broader focus on disease treatment outcomes.",
        "kind": "interpretation",
        "changes": [
          2,
          3
        ]
      }
    ],
    "written_at": "2026-11-07T14:50:34.526Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Aspect Biosystems” company record, https://startuphistory.org/c/aspectbiosystems.com"
}